BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29877755)

  • 21. In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    Wu T; Meyer K; Harrington AT; Danziger LH; Wenzler E
    J Antimicrob Chemother; 2019 May; 74(5):1300-1305. PubMed ID: 30753495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
    Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
    Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
    de Jong A; Simjee S; Garch FE; Moyaert H; Rose M; Youala M; Dry M;
    Vet Microbiol; 2018 Mar; 216():168-175. PubMed ID: 29519512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ; Arhin FF; Moeck G; Lynch TF; Sahm DF
    Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant enterococci.
    Moellering RC
    Clin Infect Dis; 1998 May; 26(5):1196-9. PubMed ID: 9597252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
    Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Chmura A; Rowiński W
    Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic options for infections due to vancomycin-resistant enterococci.
    Wang JL; Hsueh PR
    Expert Opin Pharmacother; 2009 Apr; 10(5):785-96. PubMed ID: 19351228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature.
    Bender JK; Cattoir V; Hegstad K; Sadowy E; Coque TM; Westh H; Hammerum AM; Schaffer K; Burns K; Murchan S; Novais C; Freitas AR; Peixe L; Del Grosso M; Pantosti A; Werner G
    Drug Resist Updat; 2018 Sep; 40():25-39. PubMed ID: 30447411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enterococci With Special Resistance Patterns - Epidemiology, Hygiene and Therapy].
    Mischnik A; Werner G; Bender J; Mutters NT
    Dtsch Med Wochenschr; 2019 Apr; 144(8):553-560. PubMed ID: 30986864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
    Wagenlehner FM; Lehn N; Witte W; Naber KG
    Chemotherapy; 2005 May; 51(2-3):64-9. PubMed ID: 15870498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
    Kebriaei R; Rice SA; Singh KV; Stamper KC; Dinh AQ; Rios R; Diaz L; Murray BE; Munita JM; Tran TT; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760141
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.